Pamprin Multi-Symptom

Product NDC: 71687-3003
11-digit product format: 716873003
Labeler code: 71687
Product ID: 71687-3003_4fe8f1cd-8250-e908-e063-6394a90a1173
Type: HUMAN OTC DRUG
Nonproprietary name: Acetaminophen, Pamabrom, Pyrilamine maleate
Dosage form: TABLET
Route: ORAL
Labeler: Focus Consumer Healthcare, LLC
Application: M013
Marketing category: OTC MONOGRAPH DRUG
Marketing start: 2016-06-01
Substance: PYRILAMINE MALEATE; PAMABROM; ACETAMINOPHEN
Active strength: 15; 25; 500 mg/1; mg/1; mg/1
NDC exclude flag: No
Listing certified through: 2027-12-31
Current FDA listing: Yes

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 21 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	71687-3003-4	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	71687-3003-1	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	71687-3003-4	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	71687-3003-1	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	71687-3003-4	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	71687-3003-1	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	71687-3003-4	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	71687-3003-1	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	71687-3003-4	U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	71687-3003-1	U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	71687-3003-4	U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	71687-3003-1	U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	71687-3003-4	U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	71687-3003-1	U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product: Yes
Brand name base: Pamprin Multi-Symptom
Brand name suffix: Maximum Strength
Listing expiration: 2027-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
PYRILAMINE MALEATE	15 mg/1
PAMABROM	25 mg/1
ACETAMINOPHEN	500 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 3 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
R35D29L3ZA	Internal UNII lookup
UA8U0KJM72	Internal UNII lookup
362O9ITL9D	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
1052637	Internal RxNorm lookup
1053852	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
60b3286d-5698-df50-e053-2991aa0afbe2	Available on FDA.report

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Related label table
NDC	Effective	Related label
71687-3003-1	2025-04-14	Pamprin MultiSymptom
71687-3003-4	2025-04-14	Pamprin MultiSymptom
71687-3003-1	2025-01-30	Pamprin MultiSymptom
71687-3003-4	2025-01-30	Pamprin MultiSymptom

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
71687-3003-1	Pamprin Multi-SymptomMaximum Strength	20 in 1 BOTTLE, PLASTIC	TABLET	20	5
71687-3003-1	Pamprin Multi-SymptomMaximum Strength	1 in 1 CARTON	TABLET	1	5
71687-3003-4	Pamprin Multi-SymptomMaximum Strength	1 in 1 CARTON	TABLET	1	5
71687-3003-4	Pamprin Multi-SymptomMaximum Strength	40 in 1 BOTTLE, PLASTIC	TABLET	40	5

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
71687-3003	PAMPRIN MULTI-SYMPTOM MAXIMUM STRENGTH (ACETAMINOPHEN, PAMABROM, PYRILAMINE MALEATE) TABLET [FOCUS CONSUMER HEALTHCARE, LLC]	4	Current NDC, Legacy NDC, 4 package rows	20250416_60b3286d-5698-df50-e053-2991aa0afbe2.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 44 of 79 · 1,579 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Aspirin Low Dose	ASPIRIN	ATLANTIC BIOLOGICALS CORP.	024c5054-959f-4ea5-a71f-c0e16cc4b90c	2025-06-24	Warnings	Exact identifier application number: M013
CHILDRENS ACETAMINOPHEN	CHILDRENS ACETAMINOPHEN ORAL	AARNA USA INC.	38070d15-2678-4e59-e063-6294a90ab690	2025-06-20	Warnings	Exact identifier application number: M013
TYLENOL Extra Strength	ACETAMINOPHEN	Morning Star OTC	8502ea21-937d-4b33-a3e0-ffab5dc38cd8	2025-06-19	Warnings	Exact identifier application number: M013
Tylenol PM Extra Strength	ACETAMINOPHEN AND DIPHENHYDRAMINE HYDROCHLORIDE	Morning Star OTC	6cd07a01-7034-4994-bbd3-bedcdf7d5b83	2025-06-19	Warnings	Exact identifier application number: M013
DRX CHOICE Tension Headache	ACETAMINOPHEN, CAFFEINE	Raritan Pharmaceuticals Inc.	8a5cb38b-669d-4177-b33b-d73c7ef48d18	2025-06-13	Warnings	Exact identifier application number: M013
good sense childrens pain and fever	ACETAMINOPHEN	NuCare Pharmaceuticals,Inc.	3777f4fb-d279-199d-e063-6394a90acf36	2025-06-13	Warnings	Exact identifier application number: M013
Aspirina Cafeina	ASPIRIN,CAFFEINE	Bayer HealthCare LLC.	2e709acc-325a-baca-e063-6394a90a24be	2025-06-12	Warnings	Exact identifier application number: M013
Aspirin	ASPIRIN	CHAIN DRUG MARKETING ASSOCIATION, INC.	696f55b1-536c-40c4-91f7-b572c39220db	2025-06-11	Warnings	Exact identifier application number: M013
Acetaminophen	ACETAMINOPHEN	CVS Pharmacy, Inc.	6dea9e11-ff99-63c7-e053-2a91aa0a5b54	2025-06-10	Warnings	Exact identifier application number: M013
Children Acetaminophen Oral Solution	ACETAMINOPHEN	MAJOR PHARMACEUTICALS	cfca5147-f390-40bd-8f13-c5b3b8d1c5b0	2025-06-09	Warnings	Exact identifier application number: M013
Aspirin	ASPIRIN	Trifecta Pharmaceuticals USA LLC	372be427-acbd-c10c-e063-6294a90a572d	2025-06-09	Warnings	Exact identifier application number: M013
Childrens Pain and Fever	ACETAMINOPHEN	CVS Pharmacy	d6c8118c-bf78-4194-9b14-8de33c3ecdb7	2025-06-06	Warnings	Exact identifier application number: M013
Dolo-NeuroBion	ACETAMINOPHEN	BENARD INDUSTRIES INC	b8310770-84d1-4a6f-8e23-9974947f92f1	2025-06-04	Warnings	Exact identifier application number: M013
Menstrual Complete Maximum Strength	ACETAMINOPHEN, CAFFEINE AND PYRILAMINE MALEATE	Rite Aid Corporation	69bda7d7-8660-4e8d-b8ac-892a3b1f2124	2025-06-03	Warnings	Exact identifier application number: M013
Kids Pain and Fever	ACETAMINOPHEN	KinderFarms, LLC	fb74e8f9-d72f-4681-90bd-df48364405b5	2025-06-01	Warnings	Exact identifier application number: M013
Pain and Fever Childrens	ACETAMINOPHEN	P & L Development, LLC	b815fcae-8bba-4737-ac10-29a32fb69275	2025-05-30	Warnings	Exact identifier application number: M013
Infants Pain and Fever	ACETAMINOPHEN	KinderFarms, LLC	81cc4900-226b-4c49-ba9c-5747d2a501b1	2025-05-29	Warnings	Exact identifier application number: M013
good sense pain relief pm extra strength	ACETAMINOPHEN, DIPHENHYDRAMINE HCL	Bryant Ranch Prepack	e08a7ab1-4b68-422a-97bd-2c5326633943	2025-05-29	Warnings	Exact identifier application number: M013
Acetaminophen Gelcaps	ACETAMINOPHEN	Kroger	30d3f2d0-da35-7f6f-e063-6294a90a9c22	2025-05-23	Warnings	Exact identifier application number: M013
Kids Pain and Fever	ACETAMINOPHEN	Genexa Inc.	fcffa7e6-145c-6bc0-e053-6294a90a4751	2025-05-23	Warnings	Exact identifier application number: M013

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
R35D29L3ZA	PYRILAMINE MALEATE	59-33-6	PYRILAMINE MALEATE
UA8U0KJM72	PAMABROM	606-04-2	PAMABROM
362O9ITL9D	ACETAMINOPHEN	103-90-2	ACETAMINOPHEN

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
1052637	acetaminophen 500 MG / pamabrom 25 MG / pyrilamine maleate 15 MG Oral Tablet	PSN	60b3286d-5698-df50-e053-2991aa0afbe2	5
1053852	Pamprin Max Strength Multi-Symptom 500 MG / 25 MG / 15 MG Oral Tablet	PSN	60b3286d-5698-df50-e053-2991aa0afbe2	5
1053852	acetaminophen 500 MG / pamabrom 25 MG / pyrilamine maleate 15 MG Oral Tablet [Pamprin Multi-Symptom]	SBD	60b3286d-5698-df50-e053-2991aa0afbe2	5
1052637	acetaminophen 500 MG / pamabrom 25 MG / pyrilamine maleate 15 MG Oral Tablet	SCD	60b3286d-5698-df50-e053-2991aa0afbe2	5
1052637	APAP 500 MG / pamabrom 25 MG / pyrilamine maleate 15 MG Oral Tablet	SY	60b3286d-5698-df50-e053-2991aa0afbe2	5
1053852	APAP 500 MG / pamabrom 25 MG / Pyrilamine Maleate 15 MG Oral Tablet [Pamprin Multi-Symptom]	SY	60b3286d-5698-df50-e053-2991aa0afbe2	5
1053852	Pamprin Multi-Symptom (APAP 500 MG / pamabrom 25 MG / pyrilamine maleate 15 MG) Oral Tablet	SY	60b3286d-5698-df50-e053-2991aa0afbe2	5

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Marketing end	Sample	Exclude flag	Status
71687-3003-1	71687300301	1 BOTTLE, PLASTIC in 1 CARTON (71687-3003-1) / 20 TABLET in 1 BOTTLE, PLASTIC	2016-06-01	0000-00-00	No	No	Current
71687-3003-4	71687300304	1 BOTTLE, PLASTIC in 1 CARTON (71687-3003-4) / 40 TABLET in 1 BOTTLE, PLASTIC	2016-06-01	0000-00-00	No	No	Current